Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: BeOne Medicines(688235) the Revenue is 11.58 B (+22.79%), Beat estimate;the EBIT is 2.208 B (+250.3%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
11.58B22.79%
11.00B16.58%
+0.59B6.21%
EBITExceed expectations
2.21B250.34%
1.56B146.75%
+0.65B103.59%
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf